{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:54:28Z","timestamp":1792173268375,"version":"4.4.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Focal liver lesions (FLLs) encompass a wide spectrum of benign and malignant pathologies, and accurate diagnosis is essential for appropriate management. Although advances in imaging have improved lesion characterization, histopathologic assessment remains the diagnostic gold standard for indeterminate lesions. Data on the histopathologic spectrum and diagnostic utility of ultrasound-guided percutaneous liver biopsy (US-PLB) in sub-Saharan Africa (SSA) are limited. This study aimed to characterize the histopathologic findings of US-PLB performed for FLLs at a tertiary referral center in SSA and to identify factors associated with hepatocellular carcinoma (HCC).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a retrospective observational study of adult patients (\u226518 years) who underwent US-PLB for FLL between January 2021 and December 2024 at Adera Medical and Surgical Center. Patients with indeterminate pathology results, incomplete records, biopsies performed for diffuse liver disease, or lesions classified as LI-RADS 1, 2, or 5 were excluded. Demographic, clinical, laboratory, imaging, histopathologic, and outcome data were extracted from medical records. Descriptive statistics were used to summarize patient characteristics and histopathologic diagnoses. Logistic regression analysis was performed to identify factors associated with HCC.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 119 were included in the final analysis. The median age was 56 years (IQR 45\u201365), and 59.7% were male. The median focal liver lesion size was 8.20 cm (IQR: 5.1\u201311.0 cm), with 38.7% presenting as multifocal lesions. No major biopsy-related complications were reported. HCC was the most common histopathologic diagnosis, accounting for 42.9% of cases, followed by secondary metastatic tumors (15.9%) and regenerative nodules (15.9%). Other diagnoses included chronic hepatitis (8.4%), cholangiocarcinoma (5.9%), and hepatic abscess (3.4%). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were present in 14.3% and 12.4% of patients, respectively. On multivariate analysis, HBV infection (AOR 7.85, 95% CI 1.45\u201342.60; p\u2009=\u20090.017), HCV infection (AOR 9.03, 95% CI 1.41\u201357.76; p\u2009=\u20090.020), Fibrosis-4 (FIB-4) score (AOR 1.45, 95% CI: 1.05\u20132.34: p\u2009<\u20090.01), and larger tumor size (AOR 1.27, 95% CI 1.11\u20131.46; p\u2009<\u20090.01) were significantly associated with HCC.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Ultrasound-guided percutaneous liver biopsy demonstrated a favorable safety profile for the evaluation of FLL. HCC was the predominant histopathologic diagnosis, reflecting the substantial burden of primary liver cancer in this setting. Chronic viral hepatitis and larger tumor size were significantly associated with HCC. These findings support the continued role of US-PLB in the diagnostic evaluation of indeterminate focal liver lesions and underscores the importance of viral hepatitis prevention, surveillance, and early detection strategies in sub-Saharan Africa.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0357210","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:24:26Z","timestamp":1792171466000},"page":"e0357210","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histopathologic spectrum of focal liver lesions diagnosed by ultrasound-guided percutaneous liver biopsy and predictors of hepatocellular carcinoma: A single-center experience from Sub-Saharan Africa"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-9033","authenticated-orcid":true,"given":"Tamrat Petros","family":"Elias","sequence":"first","affiliation":[{"name":"University of Rwanda","place":["Kigali, Rwanda"],"department":["Department of Internal Medicine"]},{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-4003","authenticated-orcid":true,"given":"Abate Bane","family":"Shewaye","sequence":"additional","affiliation":[{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]},{"name":"Addis Ababa University","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb Assefa","family":"Berhane","sequence":"additional","affiliation":[{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdu","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebeaman","family":"Tibebu","sequence":"additional","affiliation":[{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanuel Getu","family":"Gebreselassie","sequence":"additional","affiliation":[{"name":"Adera Medical and Surgical Center","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Sisay","family":"Abie","sequence":"additional","affiliation":[{"name":"Dilla University","place":["Dilla, Ethiopia"],"department":["Department of Internal Medicine"]},{"name":"St. Paul\u2019s Hospital Millennium Medical College","place":["Addis Ababa, Ethiopia"],"department":["Department of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"7","key":"pone.0357210.ref001","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","article-title":"ACG clinical guideline: Focal liver lesions","volume":"119","author":"C Frenette","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"pone.0357210.ref002","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"EB Tapper","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0357210.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304026","article-title":"Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis","volume":"19","author":"T P\u00f6schel","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"pone.0357210.ref004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.mayocp.2015.11.015","article-title":"Incidence and risk factors for adverse events related to image-guided liver biopsy","volume":"91","author":"JH Boyum","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"pone.0357210.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00345-5","article-title":"The burden of chronic liver disease in west Africa: A time for action","volume":"11","author":"CW Spearman","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pone.0357210.ref006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12889-024-17948-6","article-title":"Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019","volume":"24","author":"XN Wu","year":"2024","journal-title":"BMC Public Health"},{"key":"pone.0357210.ref007","first-page":"185","volume-title":"Evaluation of Focal Liver Masses. Gastrointestinal and Liver Secrets E-Book: Gastrointestinal and Liver Secrets E-Book","author":"MW Russo","year":"2023"},{"issue":"1","key":"pone.0357210.ref008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10620-021-06822-9","article-title":"Role of liver biopsy in assessment of radiologically identified liver masses","volume":"67","author":"A Khalifa","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"8","key":"pone.0357210.ref009","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"ZM Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"pone.0357210.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262903","article-title":"Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders","volume":"17","author":"DS Mbaga","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0357210.ref011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hpb.2023.09.015","article-title":"The management and outcomes of hepatocellular carcinoma in sub-Saharan Africa: A systematic review","volume":"26","author":"S Sobnach","year":"2024","journal-title":"HPB"},{"issue":"2","key":"pone.0357210.ref012","doi-asserted-by":"crossref","DOI":"10.15403\/jgld-4653","article-title":"Percutaneous CT-guided biopsy of focal liver lesions--longterm experience with more than 300 procedures","volume":"32","author":"P Hoffmann","year":"2023","journal-title":"J Gastrointest Liver Dis"},{"issue":"3","key":"pone.0357210.ref013","doi-asserted-by":"crossref","first-page":"364","DOI":"10.31688\/ABMU.2018.53.3.08","article-title":"Ultrasound-guided biopsy in focal liver lesions","volume":"53","author":"M Ilie","year":"2018","journal-title":"Arch Balk Med Union"},{"issue":"9","key":"pone.0357210.ref014","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/hep4.1974","article-title":"Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study","volume":"6","author":"A-S Duberg","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"pone.0357210.ref015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3350\/cmh.2022.0342","article-title":"Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection","volume":"29","author":"C-L Lin","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"pone.0357210.ref016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/v14050986","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"14","author":"GEM Rizzo","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"pone.0357210.ref017","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/biomedicines10123202","article-title":"Pathogenesis and current treatment strategies of hepatocellular carcinoma","volume":"10","author":"D Tuemen","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"pone.0357210.ref018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.20517\/2394-5079.2022.11","article-title":"Hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) in sub-Saharan Africa: no room for complacency","volume":"8","author":"PC Matthews","year":"2022","journal-title":"Hepatoma Res"},{"key":"pone.0357210.ref019","doi-asserted-by":"crossref","first-page":"101423","DOI":"10.1016\/j.coviro.2024.101423","article-title":"Hepatitis C virus and hepatocellular carcinoma: Carcinogenesis in the era of direct-acting antivirals","volume":"67","author":"F Fiehn","year":"2024","journal-title":"Curr Opin Virol"},{"issue":"12","key":"pone.0357210.ref020","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1111\/liv.16102","article-title":"Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysis","volume":"44","author":"GM Kassa","year":"2024","journal-title":"Liver Int"},{"issue":"9","key":"pone.0357210.ref021","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000231","article-title":"Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studies","volume":"7","author":"LE Hetland","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"pone.0357210.ref022","doi-asserted-by":"crossref","first-page":"13616","DOI":"10.1038\/s41598-021-93038-6","article-title":"Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center","volume":"11","author":"YH Roh","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0357210.ref023","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.32434","article-title":"Risk factors for HCC in contemporary cohorts of patients with cirrhosis","volume":"77","author":"F Kanwal","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"pone.0357210.ref024","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000355","article-title":"Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria","volume":"8","author":"Y Zhang","year":"2024","journal-title":"Hepatology Communications"},{"issue":"7","key":"pone.0357210.ref025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jum.15229","article-title":"Complications after percutaneous ultrasound\u2010guided liver biopsy: A systematic review and meta\u2010analysis of a population of more than 12,000 patients from 51 cohort studies","volume":"39","author":"G Tian","year":"2020","journal-title":"J Ultrasound Med"},{"issue":"7","key":"pone.0357210.ref026","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.4240\/wjgs.v15.i7.1388","article-title":"Major complications after ultrasound-guided liver biopsy: An annual audit of a Chinese tertiary-care teaching hospital","volume":"15","author":"W-L Chai","year":"2023","journal-title":"World J Gastrointest Surg"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:24:30Z","timestamp":1792171470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357210"}},"subtitle":[],"editor":[{"given":"Ashraf","family":"Elbahrawy","sequence":"first","affiliation":[{"name":"Al-Azhar University","place":["EGYPT"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357210","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}